Skip to main content

Table 1 Baseline characteristics of patients

From: Efficacy of pamidronate in children with chronic non-bacterial osteitis using whole body MRI as a marker of disease activity

Female: Male 3.18: 1
Median age at diagnosis (IQR, years) 11.6 (10–13)
Median time to diagnosis (IQR, months) 12 (5–24)
Clinical characteristics (%) Bone pain 36 (78.3)
Bone swelling 10 (21.7)
Synovitis 3 (6.5)
Arthritis 6 (13)
Pustulosis 3 (6.5)
Psoriasis 3 (6.5)
IBDa 1 (2.2)
Family history of psoriasis (%) 7 (15.2)
Family history of IBD (%) 2 (4.3)
Bone biopsy (%) 29 (63)
Lesions pre-treatment on WB-MRI 162
Treatment (%) NSAIDs 35 (76)
Pamidronate 46 (100)
Corticosteroids 4 (8.7)
Methotrexate 5 (10.9)
TNF blockers (n = 40) 5 (12.5)
  1. aIBD Inflammatory bowel disease